Arthur Chaves de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arthur Chaves de Almeida has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Virginia de Assis Silva
Mater Dei Hospital
2 shared publications - Waldeir José de Almeida
Mater Dei Hospital
2 shared publications - Ana Júlia Machado Talma
Universidade Estadual de Campinas (UNICAMP)
1 shared publication Arnaldo Gonçalves de Jesus Filho
Serviço de Ortopedia e Traumatologia do HU- UFJF, equipe de Cirurgia da Mão
1 shared publication- Barbara Bizzo Castelo
Universidade Federal de Juiz de Fora, Juiz de Fora, (MG) Brasil
1 shared publication - Gabriel Meireles Azevedo Pereira
Santa Casa de Misericórdia de Juiz de Fora
1 shared publication
Latest Publications
- Open Access
Should the use of hormones for contraception and during menopause be contraindicated in women with high-penetrance mutations?
Medical genetics is one of the fields with the greatest advancements in medical knowledge. The discovery of genes that determine greater susceptibility to certain neoplasms has motivated a vast amount aimed at determining the best management of patients with these mutations. The use of hormones, both as contraception and during menopause, for these women is a subject of ongoing debate — given their involvement in the pathophysiology of breast neoplasia. This article, therefore, aims to review the available literature on the topic. Thirteen publications were selected for narrative review. Regarding contraception, individualized assessment of these patients is still paramount in indicating hormonal contraception, with no formal contraindication to its use for patients with high-penetrance mutations. Regarding hormone therapy (HT), there are also no absolute contraindications. Consideration is only given to patients who have not undergone mastectomy. In such cases, HT can be considered for short periods, ideally using micronized progesterone in patients with a uterus.
Open AccessShould the use of hormones for contraception and during menopause be contraindicated in women with high-penetrance mutations?
Medical genetics is one of the fields with the greatest advancements in medical knowledge. The discovery of genes that determine greater susceptibility to certain neoplasms has motivated a vast amount aimed at determining the best management of patients with these mutations. The use of hormones, both as contraception and during menopause, for these women is a subject of ongoing debate — given their involvement in the pathophysiology of breast neoplasia. This article, therefore, aims to review the available literature on the topic. Thirteen publications were selected for narrative review. Regarding contraception, individualized assessment of these patients is still paramount in indicating hormonal contraception, with no formal contraindication to its use for patients with high-penetrance mutations. Regarding hormone therapy (HT), there are also no absolute contraindications. Consideration is only given to patients who have not undergone mastectomy. In such cases, HT can be considered for short periods, ideally using micronized progesterone in patients with a uterus.
- Open Access
Is the use of a dermal matrix mandatory in breast reconstruction with prosthesis after radiotherapy?
Breast reconstruction is a crucial step in the treatment of breast cancer, allowing not only the restoration of body shape but also a significant improvement in patients' quality of life. However, choosing the ideal technique is a multifactorial challenge that requires consideration of several anatomical and clinical aspects. During the Northeast Mastology Conference held in September 2024 in Natal, it was agreed by consensus that the use of a dermal matrix (ADM) is not mandatory in breast reconstruction with prosthesis after radiotherapy.
Open AccessIs the use of a dermal matrix mandatory in breast reconstruction with prosthesis after radiotherapy?
Breast reconstruction is a crucial step in the treatment of breast cancer, allowing not only the restoration of body shape but also a significant improvement in patients' quality of life. However, choosing the ideal technique is a multifactorial challenge that requires consideration of several anatomical and clinical aspects. During the Northeast Mastology Conference held in September 2024 in Natal, it was agreed by consensus that the use of a dermal matrix (ADM) is not mandatory in breast reconstruction with prosthesis after radiotherapy.
- Open Access
- 21 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Non-tubal ectopic pregnancy: types of treatment and occurrence of severe complications in a university hospital
Objective: To evaluate the types of treatments used for non-tubal ectopic pregnancy (NTEP), the success rates of medical treatment, and the incidence of severe complications. Methods: Retrospective study of all NTEP admitted in the University of Campinas (UNICAMP) Women’s hospital, Brazil, from 01/01/2000 to 01/31/2023. Outcome variables were medical treatment success and the presence […] Abstract Objective: To evaluate the types of treatments used for non-tubal ectopic pregnancy (NTEP), the success rates of medical treatment, and the incidence of severe complications. Methods: Retrospective study of all NTEP admitted in the University of Campinas (UNICAMP) Women’s hospital, Brazil, from 01/01/2000 to 01/31/2023. Outcome variables were medical treatment success and the presence […]
- 21 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Open AccessNon-tubal ectopic pregnancy: types of treatment and occurrence of severe complications in a university hospital
Objective: To evaluate the types of treatments used for non-tubal ectopic pregnancy (NTEP), the success rates of medical treatment, and the incidence of severe complications. Methods: Retrospective study of all NTEP admitted in the University of Campinas (UNICAMP) Women’s hospital, Brazil, from 01/01/2000 to 01/31/2023. Outcome variables were medical treatment success and the presence […] Abstract Objective: To evaluate the types of treatments used for non-tubal ectopic pregnancy (NTEP), the success rates of medical treatment, and the incidence of severe complications. Methods: Retrospective study of all NTEP admitted in the University of Campinas (UNICAMP) Women’s hospital, Brazil, from 01/01/2000 to 01/31/2023. Outcome variables were medical treatment success and the presence […]
- Open Access
- 9 December 2021
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 47, 1-4
Variação anatômica da musculatura do punho associada a síndrome do canal de Guyon: um relato de caso
Introdução: A síndrome do canal de Guyon é a neuropatia compressiva do nervo ulnar ao nível do punho, sendo uma de suas etiologias mais raras a presença de musculatura anômala atravessando o canal de Guyon. Objetivo: Relatar caso de paciente com síndrome do canal de Guyon causada pela presença de músculo abdutor do dedo mínimo acessório. Relato de Caso: Paciente apresentava quadro clínico com parestesia e dor em 4º e 5º dedos de membro superior direito e testes de Wartenberg e Egawa positivos. Após USG e eletroneuromiografia, foi demonstrado presença de compressão do nervo ulnar ao nível punho (síndrome de Guyon) e também ao nível do cotovelo. Durante o tratamento cirúrgico, foi observado a variação anatômica do músculo abdutor acessório do dedo mínimo, que estava de forma anômala atravessando o canal de Guyon, causando a compressão do nervo ulnar. Após o procedimento, paciente apresentou melhora dos sintomas e evoluiu bem com fisioterapia. Conclusão: A presença de músculos anômalos pode ser a causa de neuropatias compressivas. Por meio do caso relatado, contribui-se para difusão desse conhecimento a cerca dessas variações anatômicas, contribuindo para melhor manejo e tratamento dos pacientes.
- 9 December 2021
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 47, 1-4
Open AccessVariação anatômica da musculatura do punho associada a síndrome do canal de Guyon: um relato de caso
Introdução: A síndrome do canal de Guyon é a neuropatia compressiva do nervo ulnar ao nível do punho, sendo uma de suas etiologias mais raras a presença de musculatura anômala atravessando o canal de Guyon. Objetivo: Relatar caso de paciente com síndrome do canal de Guyon causada pela presença de músculo abdutor do dedo mínimo acessório. Relato de Caso: Paciente apresentava quadro clínico com parestesia e dor em 4º e 5º dedos de membro superior direito e testes de Wartenberg e Egawa positivos. Após USG e eletroneuromiografia, foi demonstrado presença de compressão do nervo ulnar ao nível punho (síndrome de Guyon) e também ao nível do cotovelo. Durante o tratamento cirúrgico, foi observado a variação anatômica do músculo abdutor acessório do dedo mínimo, que estava de forma anômala atravessando o canal de Guyon, causando a compressão do nervo ulnar. Após o procedimento, paciente apresentou melhora dos sintomas e evoluiu bem com fisioterapia. Conclusão: A presença de músculos anômalos pode ser a causa de neuropatias compressivas. Por meio do caso relatado, contribui-se para difusão desse conhecimento a cerca dessas variações anatômicas, contribuindo para melhor manejo e tratamento dos pacientes.